Back to Search
Start Over
Correction for Softley et al., 'Structure and Molecular Recognition Mechanism of IMP-13 Metallo-β-Lactamase'
- Source :
- Antimicrobial Agents and Chemotherapy
- Publication Year :
- 2020
-
Abstract
- Multidrug resistance among Gram-negative bacteria is a major global public health threat. Metallo-β-lactamases (MBLs) target the most widely used antibiotic class, the β-lactams, including the most recent generation of carbapenems. Interspecies spread renders these enzymes a serious clinical threat, and there are no clinically available inhibitors. We present the crystal structures of IMP-13, a structurally uncharacterized MBL from the Gram-negative bacterium Pseudomonas aeruginosa found in clinical outbreaks globally, and characterize the binding using solution nuclear magnetic resonance spectroscopy and molecular dynamics simulations.<br />Multidrug resistance among Gram-negative bacteria is a major global public health threat. Metallo-β-lactamases (MBLs) target the most widely used antibiotic class, the β-lactams, including the most recent generation of carbapenems. Interspecies spread renders these enzymes a serious clinical threat, and there are no clinically available inhibitors. We present the crystal structures of IMP-13, a structurally uncharacterized MBL from the Gram-negative bacterium Pseudomonas aeruginosa found in clinical outbreaks globally, and characterize the binding using solution nuclear magnetic resonance spectroscopy and molecular dynamics simulations. The crystal structures of apo IMP-13 and IMP-13 bound to four clinically relevant carbapenem antibiotics (doripenem, ertapenem, imipenem, and meropenem) are presented. Active-site plasticity and the active-site loop, where a tryptophan residue stabilizes the antibiotic core scaffold, are essential to the substrate-binding mechanism. The conserved carbapenem scaffold plays the most significant role in IMP-13 binding, explaining the broad substrate specificity. The observed plasticity and substrate-locking mechanism provide opportunities for rational drug design of novel metallo-β-lactamase inhibitors, essential in the fight against antibiotic resistance.
- Subjects :
- Pharmacology
β-lactam antibiotic
antibiotic resistance
Mechanism (biology)
Chemistry
Stereochemistry
metallo-β-lactamase
imipenemase
metalloenzyme
IMP-13
bacterial infections and mycoses
Metallo β lactamase
molecular dynamics
nuclear magnetic resonance
Infectious Diseases
Molecular recognition
Mechanisms of Resistance
protein dynamics
Pharmacology (medical)
solution NMR
X-ray crystallography
Subjects
Details
- ISSN :
- 10986596
- Volume :
- 64
- Issue :
- 7
- Database :
- OpenAIRE
- Journal :
- Antimicrobial agents and chemotherapy
- Accession number :
- edsair.doi.dedup.....c053c3979aad5f801b24c574760a9cd5